Catalyst
Slingshot members are tracking this event:
Bellicum (BLCM) Phase 1 BP-004 Data Evaluating BPX-501 and Rimiducid in Pediatric Patients After Hematopoietic Stem Cell Transplant
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| BLCM |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 23, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1, Bp-004, Bpx-501, Rimiducid, Pediatric Patients, Hematopoietic Stem Cell Transplant
